Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kinesin family member 3C (KIF3C) is a neural-enriched member of the kinesin superfamily of microtubule-dependent motor proteins[4][2][3]. It primarily forms a heterodimer with KIF3A and is involved in microtubule-based anterograde transport of membranous organelles, especially in neurons[2][4][1]. KIF3C is characterized by an N-terminal kinesin motor domain, a central stalk (predicted coiled-coil facilitating dimerization), and a C-terminal globular tail thought to interact with cargoes[2][4]. KIF3C is highly expressed in the brain, spinal cord, and retina, with notable enrichment in Purkinje cells of the cerebellum and retinal ganglion cells[4]. It plays a critical role in axonal and dendritic transport, and its dysfunction could potentially impact neuronal maintenance or neurodegenerative processes, but it is not currently established as a direct therapeutic target for drugs[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin family member 3C (KIF3C).